Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-01-27 @ 2:10 PM
Study NCT ID:
NCT01684150
Status:
COMPLETED
Last Update Posted:
2024-03-26
First Post:
2012-09-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving
Sponsor:
Epizyme, Inc.
Organization:
Conditions & Keywords Data
Conditions: